Optical coherence tomography biomarkers as outcome predictors to guide dexamethasone implant use in patients with iERM: a randomized controlled trial

Table 1 Postoperative values of BVCA and CMT

			DEX group	Wald χ² Value	P_group*time	P_time	P_group
BCVA (logMAR, Snellen), Mean (SD)	1 day	0.492 ± 0.048	0.478 ± 0.053	0.813	0.846	< 0.001	0.391
	1 week	0.365 ± 0.045	0.328 ± 0.042
	1 month	0.301 ± 0.047	0.234 ± 0.040
	3 months	0.261 ± 0.036	0.200 ± 0.044
P_time		< 0.001	< 0.001
CMT (µm), Mean (SD)	1 day	431.97 ± 14.09	430.43 ± 14.11	3.814	0.282	< 0.001	0.315
	1 week	403.36 ± 18.45	364.75 ± 18.63
	1 month	376.19 ± 20.09	347.03 ± 22.86
	3 months	362.44 ± 17.99	338.65 ± 19.41
P_time		< 0.001	< 0.001
IOP (mmHg) Mean (SD)	1 day	13.90 ± 0.74	14.97 ± 0.85	4.28	0.930	0.547	0.594
	1 week	14.43 ± 0.49	15.06 ± 0.85
	1 month	14.97 ± 1.09	15.50 ± 0.69
	3 months	14.07 ± 0.92	14.92 ± 0.68
P_time		0.497	0.928

BCVA = best corrected visual acuity; CMT = center macular thickness; IOP = intraocular pressure; SD = standard deviation. * Indicates a statistically significant difference between two groups in post hoc analysis

ISSN: 1471-2415